OSE Immunotherapeutics SA

EPA:OSE.PA

8.39 (EUR) • At close May 22, 2024
Bedrijfsnaam OSE Immunotherapeutics SA
Symbool OSE.PA
Munteenheid EUR
Prijs 8.33
Beurswaarde 155,560,551
Dividendpercentage 0%
52-weken bereik 2.705 - 8.63
Industrie Biotechnology
Sector Healthcare
CEO Dr. Nicolas Poirier Ph.D.
Website https://www.ose-immuno.com

An error occurred while fetching data.

Over OSE Immunotherapeutics SA

OSE Immunotherapeutics SA focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. Its products include Tedopi that is in Phase III clinical stage for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to

Vergelijkbare Aandelen

Novacyt S.A. logo

Novacyt S.A.

ALNOV.PA

0.73 EUR

Amplitude Surgical SA logo

Amplitude Surgical SA

AMPLI.PA

2.96 EUR

MaaT Pharma SA logo

MaaT Pharma SA

MAAT.PA

7.9 EUR

MDxHealth SA logo

MDxHealth SA

MDXH.BR

3.02 EUR

Sequana Medical NV logo

Sequana Medical NV

SEQUA.BR

1.5 EUR

Eurofins-Cerep SA logo

Eurofins-Cerep SA

ALECR.PA

21,800 EUR

UG Healthcare Corporation Limited logo

UG Healthcare Corporation Limited

8K7.SI

0.135 SGD

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)